Assertio (ASRT) to Release Quarterly Earnings on Monday

Assertio (NASDAQ:ASRT) will likely be issuing its quarterly earnings data before the market opens on Monday, March 10th. Analysts expect the company to announce earnings of ($0.05) per share and revenue of $28.67 million for the quarter. Parties interested in listening to the company’s conference call can do so using this link.

Assertio Price Performance

Shares of NASDAQ:ASRT opened at $0.78 on Friday. Assertio has a 1-year low of $0.73 and a 1-year high of $1.80. The company has a debt-to-equity ratio of 0.30, a current ratio of 2.01 and a quick ratio of 1.57. The business has a fifty day moving average price of $0.82 and a 200-day moving average price of $0.98. The company has a market capitalization of $74.65 million, a PE ratio of -1.07, a PEG ratio of 3.25 and a beta of 0.81.

Analysts Set New Price Targets

Several equities research analysts recently commented on the company. HC Wainwright reiterated a “buy” rating and issued a $4.00 price objective on shares of Assertio in a report on Monday, December 16th. StockNews.com raised Assertio from a “hold” rating to a “buy” rating in a research report on Wednesday, November 13th.

About Assertio

Assertio Holdings, Inc, a commercial pharmaceutical company, provides various products to patients in the United States. Its pharmaceutical products include INDOCIN, an oral and suppository solution for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing spondylitis and osteoarthritis; and acute painful shoulder and gouty arthritis.